Development of vaginal rings for sustained release of nonhormonal contraceptives and anti-HIV agents
Development of vaginal rings for sustained release of nonhormonal contraceptives and anti-HIV agents
复制标题
DOI:
10.1016/j.contraception.2007.04.006
复制
发表时间:
2007-08-01
期刊:
影响因子:
2.9
通讯作者:
Saxena, Brij B.
中科院分区:
文献类型:
--
作者:
Han, Young A.;Singh, Mukul;Saxena, Brij B.
Objectives: Construction of vaginal rings to deliver nonhormonal contraceptives and 3-Azido-3'-deoxythymidine (AZT) as an anti-HIV agent and determination of their daily release and efficacy in vitro.Materials and Methods: Intravaginal rings of 0.5-0.7 cm rim and 5-5.5 cm in diameter were cast in the molds. The rings were composed of biosoluble acacia gum or nonbiodegradable hydrogel of 2-hydroxyethyl methacrylate (HEMA) and sodium methacrylate (SMA) [P(HEMAco-SMA)]. The rings were impregnated with nonhormonal contraceptives such as ferrous gluconate to cause spermiostasis, L-ascorbic acid to increase the viscosity of the cervical mucus, and pharmalytes of pH 4-5 or AZT.Results: The daily release rate of nonhormonal contraceptives as well as AZT from the rings was efficacious in vitro. Cumulative effect of nonhormonal contraceptives showed complete spermiostasis within 30 s up to 10 and 28 days, respectively. Daily release of AZT from both rings was also likely to be efficacious to inhibit HIV proliferation in vitro for 10 and 28 days, respectively.Conclusion: The data indicate that the rings described here can be developed for intravaginal delivery of nonhormonal contraceptives and/or anti-HIV agents. (C) 2007 Elsevier Inc. All rights reserved.